Smoking and Diabetic Nephropathy

  • Peter T. Sawicki


In 1978, Christiansen reported that cigarette smoking is a risk factor for the development of diabetic nephropathy [1]. He found a significantly higher prevalence of persistent proteinuria among patients who were or had been cigarette smokers. In a later study by Telmer et al. [2], the earlier findings were confirmed in a greater number and better characterised group of Type 1 diabetic patients. In 668 patients, the prevalence of diabetic nephropathy was significantly higher among heavy smokers (more than 10 cigarettes per day for more than 1 year) than among other patients, that is 19% vs. 12%. In addition, a higher frequency of clinical nephropathy was found with increasing cigarette consumption. Among patients who smoked a maximum of 10 cigarettes per day, about 13% had clinical diabetic nephropathy, whereas it was more than 25% among those patients who smoked 30 cigarettes per day. An association between smoking and nephropathy was also observed by Nordén and Nyberg [3]. They compared smoking habits in 47 matched pairs of Type 1 diabetic patients with and without nephropathy. Patients with nephropathy had a significantly higher smoking index than their controls. There were also more current smokers, more heavy smokers, and fewer individuals who had never smoked in the nephropathy group than in the control group. With respect to retinopathy, study results had been controversial [4]. It is of note, that in these early studies glycosylated haemoglobin values had not been included into the analyses as a possible confounding factor.


Diabetic Patient Cigarette Smoking Diabetic Nephropathy Lupus Nephritis Nicotine Dependence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Christiansen JS. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1978; 1: 146–149.PubMedCrossRefGoogle Scholar
  2. 2.
    Telmer S, Christiansen JS, Andersen AR, Nerup J, Deckert T. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984; 215: 63–68.PubMedCrossRefGoogle Scholar
  3. 3.
    Nordén G, Nyberg G. Smoking and diabetic nephropathy. Acta Med Scand 1984; 215: 257–261.PubMedCrossRefGoogle Scholar
  4. 4.
    Mühlhauser I. Smoking and diabetes. Diabetic Med 1990; 7: 10–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Mühlhauser I, Sawicki P, Berger M. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1986; 29: 500–502.PubMedCrossRefGoogle Scholar
  6. 6.
    Stegmayr B, Lithner F. Tobacco and end stage diabetic nephropathy. BMJ 1987; 295: 581–582.PubMedCrossRefGoogle Scholar
  7. 7.
    Borch-Johnsen K, Nissen H, Henriksen E, Kreiner S, Sailing N, Deckert T, Nerup J. The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabetic Med 1987; 4: 201–210.Google Scholar
  8. 8.
    Stegmayr BG. A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. J Intern Med 1990; 228: 121–124.PubMedCrossRefGoogle Scholar
  9. 9.
    Ekberg G, Grefberg N, Larsson LO, Vaara I. Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy. J Intern Med 1990; 228: 211–217.PubMedCrossRefGoogle Scholar
  10. 10.
    Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE. Cigarette smoking increases the risk of albuminuria among subjects with Type 1 diabetes. JAMA 1991; 265: 614–617.PubMedCrossRefGoogle Scholar
  11. 11.
    Watts GF, Harris R, Shaw KM. The determinants of early nephropathy in insulin-dependent diabetes mellitus: a prospective study based on the urinary excretion of albumin. Q J Med 1991; 79 (288): 365–378.PubMedGoogle Scholar
  12. 12.
    Ekberg G, Grefberg N, Larsson LO. Cigarette smoking and urinary albumin excretion in insulin-treated diabetics without manifest nephropathy. J Intern Med 1991; 230: 435–442.PubMedCrossRefGoogle Scholar
  13. 13.
    Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992; 152: 2082–2088.Google Scholar
  14. 14.
    Klein R, Klein BEK, Moss SE. Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 1993; 42: 381–389.Google Scholar
  15. 15.
    Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 1993; 306:1235–1239.CrossRefGoogle Scholar
  16. 16.
    Mühlhauser I, Verhasselt R, Sawicki PT, Berger M. Leukocyte count, proteinuria and smoking in type 1 diabetes mellitus. Acta Diabetol 1993; 30: 105–107.PubMedCrossRefGoogle Scholar
  17. 17.
    Sawicki PT, Didjurgeit U, Mühlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17: 126–131.PubMedCrossRefGoogle Scholar
  18. 18.
    Klein R, Klein BEK, Davis MD. Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 1983; 118: 228–238.PubMedGoogle Scholar
  19. 19.
    Klein R, Klein BEK, Moss S, DeMets DL. Proteinuria in diabetes. Arch Intern Med 1988; 148: 181–186.PubMedCrossRefGoogle Scholar
  20. 20.
    Klein R, Klein BEK, Linton KLP, Moss SE. Microalbuminuria in a population-based study of diabetes. Arch Intern Med 1992; 152: 153–158.PubMedCrossRefGoogle Scholar
  21. 21.
    Dales LG, Friedman GD, Siegelaub AB, Seltzer CC, Ury HK. Cigarette smoking habits and urine characteristics. Nephron 1978; 20: 163–170.CrossRefGoogle Scholar
  22. 22.
    Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 295: 573–577.PubMedCrossRefGoogle Scholar
  23. 23.
    Baer L, Radichevich I. Cigarette smoking in hypertensive patients-blood pressure and endocrine responses. Am J Med 1985; 78: 564–568.PubMedCrossRefGoogle Scholar
  24. 24.
    Green MS, Jucha E, Luz Y. Blood pressure in smokers and non-smokers: epidemiologic findings. Am Heart J 1986; 111: 932–940.PubMedCrossRefGoogle Scholar
  25. 25.
    Mann SJ, James GD, Wang RS, Pickering TG. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case control study. JAMA 1991; 265: 2226–2228.PubMedCrossRefGoogle Scholar
  26. 26.
    Groppelli A, Giorgi DMA, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10: 495–499.PubMedCrossRefGoogle Scholar
  27. 27.
    Sawicki PT, Muhlhaser I, Bender R, Pethke W, Heinemann L, Berger M. Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy. J Intern Med 1996: 239: 345–352.PubMedCrossRefGoogle Scholar
  28. 28.
    Klein R, Moss SE, Klein BEK, DeMets DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 1989; 149: 266–272.PubMedCrossRefGoogle Scholar
  29. 29.
    Moy CS, LaPorte RE, Dorman JS, Songer TJ, Orchard TJ, Kuller LH, Becker DJ, Drash AL. Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking. Circulation 1990; 82: 37–43.PubMedCrossRefGoogle Scholar
  30. 30.
    Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ 1989; 299: 1127–1131.PubMedCrossRefGoogle Scholar
  31. 31.
    Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics) II: associated risk factors. Diabetologia 1990; 33: 542–548.PubMedCrossRefGoogle Scholar
  32. 32.
    Ford ES, DeStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I. Epidemiological follow-up study. Am J Epidemiol 1991; 133: 1220–1230.PubMedGoogle Scholar
  33. 33.
    Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–1147.PubMedCrossRefGoogle Scholar
  34. 34.
    Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr. cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434–444.PubMedCrossRefGoogle Scholar
  35. 35.
    Manske CL, Wilson RF, Wang Y, Thomas W. Prevalence of, and risk factors for, angiographically determined coronary artery disease in Type 1 diabetic patients with nephropathy. Arch Intern Med 1992; 152: 2450–2455.PubMedCrossRefGoogle Scholar
  36. 36.
    Perry RJ, Griffiths W, Dextraze P, Solomon RJ, Trebbin WM. Elevated nicotine levels in patients undergoing hemodialysis. A role in cardiovascular mortality and morbidity? Am J Med 1984; 76: 241–246.PubMedCrossRefGoogle Scholar
  37. 37.
    Ardron M, MacFarlane IA, Robinson C, van Heyningen C, Calverley PMA. Anti-smoking advice for young diabetic smokers: is it a waste of breath? Diabetic Med 1988; 5: 667–670.PubMedCrossRefGoogle Scholar
  38. 38.
    Fowler PM, Hoskins PL, McGill M, Dutton SP, Yue DK, Turtle JR. Anti-smoking programme for diabetic patients: the agony and the ecstasy. Diabetic Med 1989; 6: 698–702.PubMedCrossRefGoogle Scholar
  39. 39.
    Sawicki PT, Didjurgeit U, Miihlhauser I, Berger M. Behaviour therapy versus doctor’s anti-smoking advice in diabetic patients. J Intern Med 1993; 234: 407–409.PubMedCrossRefGoogle Scholar
  40. 40.
    Mühlhauser I, Bender R, Bott U, Jorgens V, Grusser M, Wagener W, Overmann H, Berger M. Cigarette-smoking and progression of retinopathy and nephropathy in type-1 diabetes. Diabetic Med 1996; 13: 536–543.PubMedCrossRefGoogle Scholar
  41. 41.
    Baumgartl H-J, Standi E, Vlassara H, Bucala R. Increase in serum ages (“advanced glycosylation end-products”) in IDDM patients who smoke (Abstract). Diabetologia 1996; 39: Suppl. 1: A291.Google Scholar
  42. 42.
    Fortmannn SP. Smoking: No time for complacency. Cardiovasc Risk Factors 1996; 6: 123–125.Google Scholar
  43. 43.
    Joossens L. Trends in uptake and quitting smoking in Europe. Cardiovasc Risk Factors 1996; 6: 126–129.Google Scholar
  44. 44.
    Kunze M. Epidemiology of nicotine dependence and general aspectss of smoking cessation. Cardiovasc Risk Factors 1996; 6: 130–134.Google Scholar
  45. 45.
    Fagerström KO, Säwe U. The pathophysiology of nicotine dependence: treatment options and the cardiovascular safety of nicotine. Cardiovasc Risk Factors 1996; 6: 135–143.Google Scholar
  46. 46.
    Wilhelmsen L. Benefits of quitting smoking for cardiac disease. Cardiovasc Risk Factors 1996; 6: 144–147.Google Scholar
  47. 47.
    Hansen HP, Rossing K, Jacobsen P, Jensen BR, Parving H-H. The acute effect of smoking on systemic hemodynamics, kidney and endothelian functions in insulin-dependent diabetic patients with microalbuminuria. Scand J Clin Lab Invest 1996; 56: 393–399.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Peter T. Sawicki
    • 1
  1. 1.Medizinische Klinik und Poliklinik, Klinik f. Stoffwechselkrankheiten und ErnährungDüsseldorfGermany

Personalised recommendations